Nov.—New investor Johnson & Johnson Development Corp. has joined current shareholders New Enterprise Associates and Google Ventures, plus five undisclosed backers in 23andMe Inc.'s (personalized genetics) $22.2mm Series C venture round. According to the Form D filing, the company could bring in another $7.8mm before closing the financing.
Oct.—Eight-year-old Aureon Biosciences Inc. (sells a prognostic test for patients diagnosed with prostate cancer) has raised almost $5mm through...